fate
The problem, dear rickyp, is that central planning has consequences. You like to believe it doesn't
Right now there is central planning. By the small number of large pharmaceutical manufacturers....
You're worrying about a hypothetical. You can't prove there would be any difference in research and development if medicare and medicaid negotiated lower drug prices...
Why?
1) Most original research doesn't have its genesis in corporations....
2) R&D spending has a ludicrously wide definition when it comes to expense claims at tax time... So current spending levels are greatly exaggerated. And include research on a lot of largely incidental changes to drugs to justify patent protection continuations....
Moreover, you're using a hypothetical as weight against a known benefit. That's the kind of thing you accuse liberals of all the time...
Look, if drug negotiations could reduce costs 20% .... and that's likely .... there'd be a lot of room to move on new approaches to funding research if it really is required....
I doubt it though. R&D is required in order for growth by Pharma. They won't stop developing products that are their future . They'll save on the wasteful stuff like marketing and detailing...
The problem, dear rickyp, is that central planning has consequences. You like to believe it doesn't
Right now there is central planning. By the small number of large pharmaceutical manufacturers....
You're worrying about a hypothetical. You can't prove there would be any difference in research and development if medicare and medicaid negotiated lower drug prices...
Why?
1) Most original research doesn't have its genesis in corporations....
2) R&D spending has a ludicrously wide definition when it comes to expense claims at tax time... So current spending levels are greatly exaggerated. And include research on a lot of largely incidental changes to drugs to justify patent protection continuations....
Moreover, you're using a hypothetical as weight against a known benefit. That's the kind of thing you accuse liberals of all the time...
Look, if drug negotiations could reduce costs 20% .... and that's likely .... there'd be a lot of room to move on new approaches to funding research if it really is required....
I doubt it though. R&D is required in order for growth by Pharma. They won't stop developing products that are their future . They'll save on the wasteful stuff like marketing and detailing...